z-logo
open-access-imgOpen Access
Anti-Fibrotic Effects of Astragaloside IV in Systemic Sclerosis
Author(s) -
Qing Qi,
Yueping Mao,
Juanjuan Yi,
Donghai Li,
Ke Zhu,
Xushan Cha
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000366405
Subject(s) - fibronectin , fibroblast , western blot , fibrosis , in vivo , bleomycin , chemistry , smad , pharmacology , systemic administration , medicine , transforming growth factor , endocrinology , pathology , biology , in vitro , cell , biochemistry , chemotherapy , microbiology and biotechnology , gene
To evaluate the anti-fibrotic effects of Astragaloside IV in systemic sclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom